Natco launches Bortenat injection
Natco launches Bortenat injection
Natco Pharma has launched a new product, Bortezomib 3.5 mg injection, under the brand name Bortenat. Bortenai is used in the treatment of multiple myeloma and is the first time launch of the Bortezomib generic in India, the company said in a statement.
Source : ET